Ottavia Amato

439 total citations
12 papers, 270 citations indexed

About

Ottavia Amato is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ottavia Amato has authored 12 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ottavia Amato's work include HER2/EGFR in Cancer Research (4 papers), Advanced Breast Cancer Therapies (3 papers) and Breast Cancer Treatment Studies (3 papers). Ottavia Amato is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Advanced Breast Cancer Therapies (3 papers) and Breast Cancer Treatment Studies (3 papers). Ottavia Amato collaborates with scholars based in Italy, Belgium and Cyprus. Ottavia Amato's co-authors include Valentina Guarneri, Michele Bottosso, Gaia Griguolo, Tommaso Giarratano, Marcello Mele, Matilde Cacciatore, Grazia Maria Vernaci, Debora De Bartolo, Federica Miglietta and Maria Vittoria Dieci and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Ottavia Amato

11 papers receiving 267 citations

Peers

Ottavia Amato

ONCOL

RNMI

PRM

Elisa Genovesi Italy

Danai Fimereli Belgium

SM Swain United States

Ning Liao China

Hans Wildiers Belgium

Donggeng Liu China

Yizhao Xie China

Pamela Trillo Aliaga Italy

Jason Mouabbi United States

E.P. Hamilton United States

Elisa Genovesi Italy

Ottavia Amato

251 ×1.2

ONCOL

157 ×1.3

123 ×1.1

RNMI

75 ×1.0

PRM

23 ×0.6

Citations per year, relative to Ottavia Amato Ottavia Amato (= 1×) peers Elisa Genovesi

Countries citing papers authored by Ottavia Amato

Since Specialization

Citations

This map shows the geographic impact of Ottavia Amato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ottavia Amato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ottavia Amato more than expected).

Fields of papers citing papers by Ottavia Amato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ottavia Amato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ottavia Amato. The network helps show where Ottavia Amato may publish in the future.

Co-authorship network of co-authors of Ottavia Amato

This figure shows the co-authorship network connecting the top 25 collaborators of Ottavia Amato. A scholar is included among the top collaborators of Ottavia Amato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ottavia Amato. Ottavia Amato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Ruggieri, Lorenzo, Ottavia Amato, Davide Dalu, et al.. (2024). Rising Concern About the Carcinogenetic Role of Micro-Nanoplastics. International Journal of Molecular Sciences. 26(1). 215–215. 1 indexed citations

Amato, Ottavia, et al.. (2024). Circulating tumor DNA validity and potential uses in metastatic breast cancer. npj Breast Cancer. 10(1). 21–21. 20 indexed citations

Cona, Maria Silvia, Lorenzo Ruggieri, Salvatore Artale, et al.. (2024). 390P SARELIFE: An Italian, multicentric real-world study of sacituzumab govitecan (SG) in pretreated metastatic triple-negative breast cancer (mTNBC). Annals of Oncology. 35. S381–S382. 1 indexed citations

Amato, Ottavia, Laurence Buisseret, Géraldine Gebhart, et al.. (2023). PIK3CAcopy-number gain and inhibitors of the PI3K/AKT/mTOR pathway in triple-negative breast cancer. Molecular Case Studies. 9(2). a006255–a006255. 5 indexed citations

Amato, Ottavia, Valentina Guarneri, & Fabio Girardi. (2023). Epidemiology trends and progress in breast cancer survival: earlier diagnosis, new therapeutics. Current Opinion in Oncology. 35(6). 612–619. 10 indexed citations

Barbieri, Caterina, Ottavia Amato, Loris Marin, et al.. (2023). Fertility Counseling Pattern over Time in Young Patients with Breast Cancer: A Retrospective Analysis at a Large Comprehensive Cancer Center. SHILAP Revista de lepidopterología. 50(6). 2 indexed citations

Miglietta, Federica, Ottavia Amato, Gaia Griguolo, et al.. (2023). PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2− BC patients with residual disease after neoadjuvant chemotherapy: a cohort study. Journal of Clinical Pathology. 77(10). 690–696. 1 indexed citations

Miglietta, Federica, Gaia Griguolo, Michele Bottosso, et al.. (2022). HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment. npj Breast Cancer. 8(1). 66–66. 75 indexed citations

Miglietta, Federica, Gaia Griguolo, Michele Bottosso, et al.. (2021). Evolution of HER2-low expression from primary to recurrent breast cancer. npj Breast Cancer. 7(1). 137–137. 150 indexed citations

10.

Bottosso, Michele, Tommaso Giarratano, Caterina Barbieri, et al.. (2021). 122P Abemaciclib in HR+/HER2- metastatic breast cancer: A real-world experience. Annals of Oncology. 32. S73–S74.

11.

Marino, Dario, Silvia Finotto, Umberto Basso, et al.. (2020). To Transplant or Not to Transplant During the SARS-CoV-2 Pandemic? That Is the Question. The Oncologist. 26(2). e336–e337. 1 indexed citations

12.

Cucchiari, David, Irene Colombo, Ottavia Amato, et al.. (2017). Exertional rhabdomyolysis leading to acute kidney injury: when genetic defects are diagnosed in adult life. CEN Case Reports. 7(1). 62–65. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact